MedPath

Ceramic Modular Dual Mobility in Primary Total Hip Arthroplasty (THA)

Not Applicable
Recruiting
Conditions
Coxarthrosis; Primary
Interventions
Device: Standard Acetabular component
Device: Dual Mobility Cup
Registration Number
NCT05547984
Lead Sponsor
Aesculap AG
Brief Summary

A randomized controlled trial comparing modular dual mobility inserts with ceramic multilayer coating versus standard polyethylene inserts for primary THA in a cementless acetabular cup

Detailed Description

The aim of this study is to show in a randomized controlled trial that cobalt and chromium ion serum levels are comparable to the metal ion levels in patients with standard articulation with metal head. The metal on polyethylene articulation is accepted as standard articulation since many decades, and which is currently in the Czech Republic the most used combination. Most studies which focused on the topic of metal ion release from modular dual mobility systems do not present results of a control group with standard articulation hip implants.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Primary coxarthrosis patients indicated for cementless total hip arthroplasty
  • Written informed patient consent
Exclusion Criteria
  • Hip trauma or revision surgery
  • Rheumatoid or neurologic disease
  • BMI >35
  • Ongoing oncologic therapy
  • Preoperatively elevated Co or Cr serum levels >1.0 µg/L
  • Patients with other joint implants, or anticipated need for another joint replacement surgery within the study period
  • Acetabular cup size <52 expected
  • Patients not able to mentally or physically comply with the study demands and follow-up visits
  • Patients <18 years at surgery
  • Pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Standard Acetabular componentStandard Acetabular componentstandard articulation with polyethylene + vitamin E inlay and metal head
Dual Mobility CupDual Mobility Cupdual mobility articulation
Primary Outcome Measures
NameTimeMethod
Serum metal ion analysis (Chromium)12 months after surgery

Chromium ion levels in blood serum in measured in \[µg/L\], Comparison between the two groups

Serum metal ion analysis (Cobalt)12 months after surgery

Cobalt ion levels in blood serum in measured in \[µg/L\], Comparison between the two groups

Secondary Outcome Measures
NameTimeMethod
Radiologic Evaluation: center of rotationimmediately postoperative, 3 months, 12 months and 3 years postoperative

Centre of Rotation (CoR) is defined as the zero position for the measurement of potential cup migration. Horizontal: Distance of CoR to ipsilateral teardrop; Vertical: Distance CoR to Inter-teardrop line; The comparison of the intraoperatively center of rotation and the center of rotation at different follow-up examinations allows prediction on longterm success.

Radiologic Evaluation: Radiolucencies around the cupover follow-up period 3 months, 12 months and 3 years postoperative

Bony Osseointegration or conspicuous features of the cup are assessed on anterior-posterior and lateral x-rays of the cup and will be analysed according to the zones defined by Charnley. "Charnley" zones of the acetabular component are distinct zones used in assessment of aseptic loosening in total hip joint replacements. The radiolucencies are categorized to "none", "less than or equal to 2mm" and "more than 2 mm"

Radiological Outcome: Heterotopic Ossificationover follow-up period 3 months, 12 months and 3 years postoperative

Brooker classification divides heterotopic ossifications that form following total hip replacement to four classes. Class I: islands of bone within soft tissues around hip; Class II: bone spurs in pelvis or proximal end of femur leaving ≥1 cm between the opposing bone surfaces; Class III: bone spurs that extend from pelvis or the proximal end of femur, which reduce the space between the opposing bone surfaces to \<1cm; Class IV: ankylosis of the hip on x-ray

Change of functional outcome over three year follow-up period (Harris Hip Score)3 months, 12 months and 3 years postoperatively

The Harris Hip Score (HHS) is one of the most used scores in total hip arthroplasty, mainly combining range of motion questions with questions regarding daily life activities. The HHS is a measure of dysfunction so the higher the score, the better the outcome for the individual. Results can be recorded and calculated online. The maximum score possible is 100, any result \<70 is considered a poor result; The HHS is an outcome measure administered by a qualified health care professional, such as a physician or a physical therapist.

Gait analysis over timepreoperative, 3 months and 12 months postoperatively

The gait lab analysis involves a high amount of recorded data and variables. Gait lab analyses are performed with the patients between the preoperative state, 3 months after surgery and 1 year postoperative. The Gait Profile Score (GPS) is used as a measure for the deviation in gait kinematics from a healthy patient population to compare the two treatment groups.

Lower score values can be considered as a sign of better restoration of the physiological gait kinematics.

Development of Patient satisfaction with surgery result over timeat three examinations during Follow-Up (3 months postop, 1 year postop, 3 years postop)

Patient is asked for satisfaction with surgery result with a 4-point scale: very satisfied, satisfied, unsatisfied, very unsatisfied

Radiologic Evaluation: Cup Inclination over timeimmediately postoperative, 3 months, 12 months and 3 years postoperative

Inclination is the orientation of the cup in the coronal plane. The target acetabular cup inclination is a "safe zone" between 30-50° abduction (assessed on antero-posterior (ap) x-rays of the hip). The comparison of the intraoperatively achieved inclination and the inclination at different follow-up examinations allows prediction on longterm success.

Trial Locations

Locations (1)

Masaryk Hospital

🇨🇿

Ústí nad Labem, Czechia

© Copyright 2025. All Rights Reserved by MedPath